GSK Investigational Site

Santo André, São Paulo 09190-615

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Lung Cancer, Non-Small Cell, Neoplasms, Breast, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) — Completed
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma — Completed
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed